BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 7
• 8
• 9
• 10
• 11
• 14
• 15
• 16
• 17
• 18
• 21
• 22
• 23
• 24
• 25
• 29
• 30
• 31

• Policy

  Johnson & Johnson and Bayer HealthCare Seek Added Use for Xarelto

  May 3, 2012

   · 

  1 min read
• Business

  Silence Therapeutics plc’ Partner, Quark Pharmaceuticals Inc., Extends its Agreement With Pfizer Inc. to Develop one of Its Compounds Containing Silence’s AtuRNAi in a New Indication

  May 3, 2012

   · 

  7 min read
• Business

  NuPathe Inc. to Report First Quarter 2012 Results and Hold Conference Call on Thursday, May 10, 2012

  May 3, 2012

   · 

  2 min read
• Business

  The Alliance for Regenerative Medicine (ARM) Holds Clinical Outlooks for Regenerative Medicine Meeting in Partnership With Harvard Stem Cell Institute

  May 3, 2012

   · 

  4 min read
• Biotech Bay

  New Data on Edwards Lifesciences Corporation’s EDWARDS INTUITY Valve System Demonstrate Promise of Rapid Deployment Platform

  May 3, 2012

   · 

  4 min read
• Business

  Hansen Medical Reports First Quarter 2012 Results

  May 3, 2012

   · 

  14 min read
• Business

  Zealand Pharma Signs Licensing Agreement With Abbott Laboratories for the Further Clinical Development and Commercialization of AP214 (ZP1480) for Prevention of Acute Kidney Injury

  May 3, 2012

   · 

  1 min read
• Drug Development

  Oxygen Biotherapeutics, Inc. Secures Long-Term Clinical Supply of Oxycyte(R)

  May 3, 2012

   · 

  1 min read
• Lone Star Bio

  Pain Therapeutics Release: Four U.S. Patents Issued for REMOXY

  May 3, 2012

   · 

  1 min read
• Business

  NovaBay Pharmaceuticals, Inc. Provides Q1 - 2012 Financial Results

  May 3, 2012

   · 

  1 min read